Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:56.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:20:48.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:29:43.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A 'Show glossary' toggle was added, the QC update label was changed to 'Last Update Submitted that Met QC Criteria', and a 'No FEAR Act Data' notice along with revision v3.4.0 was added.
    Difference
    0.2%
    Check dated 2026-01-28T21:24:51.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page, a minor metadata change that does not affect study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:39:03.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section highlighting Arizona and updated the page revision from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure footer link was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T20:41:08.000Z thumbnail image

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.